April 2, 2019
The Japan arm of Mundipharma and Maruishi Pharmaceutical said on April 1 that they will start copromoting the UK-based company’s cancer pain medicine Tapenta Tablets (tapentadol) in Japan, beginning in June. Mundipharma acquired Japan rights to Tapenta from Janssen in...read more